14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jan 02, 2020 Buy 10 000 Brandt Ralf Stock Option (right to buy)
Jan 02, 2020 Buy 10 000 Miles Michael Glenn Stock Option (right to buy)
Jul 23, 2019 Buy 100 000 Prendergast Franklyn G Stock Option (right to buy)
Jul 23, 2019 Buy 100 000 Harris Geoffrey E. Stock Option (right to buy)
Jan 31, 2019 Buy 185 436 Roberts John A Common Stock, par value $0.0001 per share
Jan 31, 2019 Buy 150 000 Miles Michael Glenn Common Stock, par value $0.0001 per share
Jan 31, 2019 Buy 1 000 000 Pappajohn John Common Stock, par value $0.0001 per share
Jan 14, 2019 Buy 100 000 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Jan 14, 2019 Buy 1 000 000 Pappajohn John Common Stock, par value $0.0001 per share
Jan 14, 2019 Buy 100 000 Roberts John A Common Stock, par value $0.0001 per share
Nov 26, 2018 Buy 100 000 Miles Michael Glenn Stock Option (right to buy)
May 10, 2018 Buy 150 000 Brandt Ralf Stock Option (right to buy)
May 10, 2018 Buy 350 000 Roberts John A Stock Option (right to buy)
Dec 15, 2017 Buy 12 200 Roberts John A Common Stock
Dec 08, 2017 Buy 150 000 Pappajohn John Common Stock, par value $0.0001 per share
Oct 01, 2017 Buy 100 000 Brandt Ralf Stock Option (right to buy)
Sep 28, 2017 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Sep 28, 2017 Buy 5 000 Pappajohn John Stock Option (right to buy)
Sep 28, 2017 Buy 2 500 Prendergast Franklyn G Common Stock, par value $0.0001 per share
Sep 28, 2017 Buy 5 000 Prendergast Franklyn G Stock Option (right to buy)
Sep 28, 2017 Buy 2 500 Welsh Michael J. Common Stock, par value $0.0001 per share
Sep 28, 2017 Buy 5 000 Welsh Michael J. Stock Option (right to buy)
Sep 28, 2017 Buy 2 500 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Sep 28, 2017 Buy 5 000 Harris Geoffrey E. Stock Option (right to buy)
Aug 18, 2017 Buy 20 000 Pappajohn John Common Stock, par value $0.0001 per share
Aug 17, 2017 Buy 66 185 Pappajohn John Common Stock, par value $0.0001 per share
Aug 17, 2017 Buy 20 000 Pappajohn John Common Stock, par value $0.0001 per share
Aug 15, 2017 Buy 0 Brandt Ralf Common Stock, par value $0.0001 per share
Aug 15, 2017 Buy 0 Brandt Ralf Common Stock, par value $0.0001 per share
Jun 12, 2017 Buy 100 000 Pappajohn John Common Stock, par value $0.0001 per share
Jun 07, 2017 Buy 2 500 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Jun 07, 2017 Buy 10 000 Harris Geoffrey E. Stock Option (right to buy)
Jun 07, 2017 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Jun 07, 2017 Buy 10 000 Pappajohn John Stock Option (right to buy)
Jun 07, 2017 Buy 10 000 Prendergast Franklyn G Stock Option (right to buy)
Jun 07, 2017 Buy 2 500 Prendergast Franklyn G Common Stock, par value $0.0001 per share
Jun 07, 2017 Buy 2 500 Welsh Michael J. Common Stock, par value $0.0001 per share
Jun 07, 2017 Buy 10 000 Welsh Michael J. Stock Option (right to buy)
May 25, 2017 Buy 937 Gitelman Igor Common Stock, par value $0.0001 per share
May 23, 2017 Sell 937 Gitelman Igor Stock Option (right to buy)
May 23, 2017 Buy 937 Gitelman Igor Common Stock, par value $0.0001 per share
May 23, 2017 Sell 937 Gitelman Igor Common Stock, par value $0.0001 per share
May 16, 2017 Buy 19 310 Pappajohn John Common Stock, par value $0.0001 per share
May 16, 2017 Buy 2 500 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Feb 22, 2017 Buy 30 000 Roberts John A Stock Option (right to buy)
Feb 22, 2017 Buy 15 000 Gitelman Igor Stock Option (right to buy)
Feb 13, 2017 Buy 0 Gitelman Igor
Dec 14, 2016 Buy 2 500 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Nov 28, 2016 Buy 100 000 Pappajohn John Common Stock, par value $0.0001 per share
Nov 14, 2016 Buy 5 000 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Nov 14, 2016 Buy 31 100 Pappajohn John Common Stock, par value $0.0001 per share
Oct 11, 2016 Buy 10 000 Prendergast Franklyn G Stock Option (right to buy)
Oct 11, 2016 Buy 2 500 Prendergast Franklyn G Common Stock, par value $0.0001 per share
Oct 11, 2016 Buy 2 500 Harris Geoffrey E. Common Stock, par value $0.0001 per share
Oct 11, 2016 Buy 10 000 Harris Geoffrey E. Stock Option (right to buy)
Oct 11, 2016 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Oct 11, 2016 Buy 10 000 Pappajohn John Stock Option (right to buy)
Oct 11, 2016 Buy 10 000 Welsh Michael J. Stock Option (right to buy)
Oct 11, 2016 Buy 2 500 Welsh Michael J. Common Stock, par value $0.0001 per share
Aug 16, 2016 Buy 45 000 Pappajohn John Common Stock, par value $0.0001 per share
Aug 15, 2016 Buy 79 722 Pappajohn John Common Stock, par value $0.0001 per share
Aug 12, 2016 Buy 67 778 Pappajohn John Common Stock, par value $0.0001 per share
Jul 11, 2016 Buy 120 000 Roberts John A Stock Option (right to buy)
Jul 11, 2016 Buy 0 Roberts John A
May 25, 2016 Buy 317 820 Pappajohn John Common Stock, par value $0.0001 per share
May 25, 2016 Buy 317 820 Pappajohn John Common Stock, par value $0.0001 per share
May 25, 2016 Buy 158 910 Pappajohn John Warrant (right to buy)
Mar 17, 2016 Buy 50 000 Pappajohn John Common Stock, par value $0.0001 per share
Mar 16, 2016 Buy 40 Welsh Michael J. Common Stock, par value $0.0001 per share
Mar 16, 2016 Buy 10 579 Pappajohn John Common Stock, par value $0.0001 per share
Mar 15, 2016 Buy 89 421 Pappajohn John Common Stock, par value $0.0001 per share
Nov 12, 2015 Buy 100 000 Pappajohn John Common Stock, par value $0.0001 per share
Nov 12, 2015 Buy 100 000 Pappajohn John Warrant (right to buy)
Oct 14, 2015 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Oct 14, 2015 Buy 10 000 Pappajohn John Stock Option (right to buy)
Aug 27, 2015 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Aug 27, 2015 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Aug 26, 2015 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
Aug 26, 2015 Buy 2 500 Pappajohn John Common Stock, par value $0.0001 per share
May 14, 2015 Buy 10 000 Prendergast Franklyn G Stock Option (right to buy)
May 14, 2015 Buy 5 000 Pappajohn John Common Stock, par value $0.0001 per share
May 14, 2015 Buy 10 000 Welsh Michael J. Stock Option (right to buy)
May 14, 2015 Buy 5 000 Harris Geoffrey E. Common Stock
May 14, 2015 Buy 10 000 Harris Geoffrey E. Stock Option (right to buy)
May 14, 2015 Buy 5 000 Harris Geoffrey E. Common Stock
Mar 17, 2015 Buy 15 000 Pappajohn John Common Stock, par value $0.0001 per share
Mar 16, 2015 Buy 35 000 Pappajohn John Common Stock, par value $0.0001 per share
Dec 16, 2014 Buy 5 589 Pappajohn John Common Stock, par value $0.0001 per share
Dec 15, 2014 Buy 3 634 Pappajohn John Common Stock, par value $0.0001 per share
Dec 11, 2014 Buy 10 000 El Naggar Jane Houldsworth Stock Option (right to buy)
Dec 11, 2014 Buy 5 000 Harris Geoffrey E. Stock Option (right to buy)
Dec 11, 2014 Buy 27 087 Pappajohn John Common Stock, par value $0.0001 per share
Dec 10, 2014 Buy 5 773 Pappajohn John Common Stock, par value $0.0001 per share
Dec 09, 2014 Buy 15 986 Pappajohn John Common Stock, par value $0.0001 per share
Dec 08, 2014 Buy 0 Harris Geoffrey E.
Dec 08, 2014 Buy 23 700 Pappajohn John Common Stock, par value $0.0001 per share
Jun 10, 2014 Buy 44 288 Pappajohn John Common Stock, par value $0.0001 per share
Jun 10, 2014 Buy 44 288 Pappajohn John Warrant (right to buy)
May 22, 2014 Buy 10 000 Prendergast Franklyn G Stock Option (right to buy)
May 22, 2014 Sell 10 000 Welsh Michael J. Stock Option (right to buy)
INSIDER POWER
0
Last 100 transactions
Buy: 5 931 040 | Sell: 11 874 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 5 931 040 and sold 11 874 CGIX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Cancer Genetics

Cancer Genetics Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug... CGIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT